You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 293 No. 13, April 6, 2005 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Editorial
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (2)
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in JAMA
 Topic Collections
 •Aging/ Geriatrics
 •Cardiovascular System
 •Cardiovascular Disease/ Myocardial Infarction
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Cardiovascular Risk Stratification in Older Patients

Role of Brain Natriuretic Peptide, C-Reactive Protein, and Urinary Albumin Levels

Martin Schillinger, MD

JAMA. 2005;293:1667-1669.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Cardiovascular risk prediction by noninvasive laboratory testing in the general population is becoming increasingly recognized as an important health care issue. During the last decade, a variety of novel potentially powerful prognostic biomarkers emerged, which may yield prognostic information even in individuals without evidence of prevalent disease. Among the panel of promising parameters, the role of natriuretic peptides and inflammatory markers has been extensively studied in various populations and clinical settings. Natriuretic peptides have been shown to predict outcome of patients with heart failure, coronary artery, and valvular heart disease.1-4 However, unlike studies examining C-reactive protein (CRP),5-7 investigations of natriuretic peptides in predicting future cardiovascular events have not been conducted in population-based samples, and comparative analyses including a variety of prognostic biomarkers are scarce.5, 8

In this issue of JAMA, Kistorp and colleagues9 assessed the ability of N-amino terminal fragment of the prohormone brain natriuretic peptide (NT-proBNP) to . . . [Full Text of this Article]

Author Affiliation: Department of Internal Medicine, University of Vienna, Medical School, Vienna, Austria.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLE

N-Terminal Pro-Brain Natriuretic Peptide, C-Reactive Protein, and Urinary Albumin Levels as Predictors of Mortality and Cardiovascular Events in Older Adults
Caroline Kistorp, Ilan Raymond, Frants Pedersen, Finn Gustafsson, Jens Faber, and Per Hildebrandt
JAMA. 2005;293(13):1609-1616.
ABSTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

BNP Associated with Cardiovascular Risk
JWatch General 2005;2005:5-5.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2005 American Medical Association. All Rights Reserved.